Legal & General Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $841M | Sell |
|
|||||
|
2025
Q1 | $918M | Buy |
|
|||||
|
2024
Q4 | $759M | Sell |
|
|||||
|
2024
Q3 | $886M | Sell |
|
|||||
|
2024
Q2 | $924M | Sell |
|
|||||
|
2024
Q1 | $847M | Sell |
|
|||||
|
2023
Q4 | $839M | Buy |
|
|||||
|
2023
Q3 | $710M | Sell |
|
|||||
|
2023
Q2 | $749M | Buy |
|
|||||
|
2023
Q1 | $657M | Buy |
|
|||||
|
2022
Q4 | $587M | Sell |
|
|||||
|
2022
Q3 | $619M | Sell |
|
|||||
|
2022
Q2 | $620M | Buy |
|
|||||
|
2022
Q1 | $537M | Buy |
|
|||||
|
2021
Q4 | $417M | Sell |
|
|||||
|
2021
Q3 | $375M | Buy |
|
|||||
|
2021
Q2 | $393M | Buy |
|
|||||
|
2021
Q1 | $367M | Sell |
|
|||||
|
2020
Q4 | $407M | Buy |
|
|||||
|
2020
Q3 | $459M | Buy |
|
|||||
|
2020
Q2 | $476M | Buy |
|
|||||
|
2020
Q1 | $377M | Buy |
|
|||||
|
2019
Q4 | $332M | Buy |
|
|||||
|
2019
Q3 | $248M | Buy |
|
|||||
|
2019
Q2 | $268M | Buy |
|
|||||
|
2019
Q1 | $267M | Buy |
|
|||||
|
2018
Q4 | $191M | Buy |
|
|||||
|
2018
Q3 | $207M | Buy |
|
|||||
|
2018
Q2 | $179M | Sell |
|
|||||
|
2018
Q1 | $179M | Sell |
|
|||||
|
2017
Q4 | $173M | Sell |
|
|||||
|
2017
Q3 | $179M | Buy |
|
|||||
|
2017
Q2 | $147M | Buy |
|
|||||
|
2017
Q1 | $119M | Buy |
|
|||||
|
2016
Q4 | $77.2M | Buy |
|
|||||
|
2016
Q3 | $90.5M | Buy |
|
|||||
|
2016
Q2 | $88.3M | Buy |
|
|||||
|
2016
Q1 | $77.6M | Sell |
|
|||||
|
2015
Q4 | $123M | Buy |
|
|||||
|
2015
Q3 | $101M | Buy |
|
|||||
|
2015
Q2 | $116M | Buy |
|
|||||
|
2015
Q1 | $108M | Sell |
|
|||||
|
2014
Q4 | $109M | Sell |
|
|||||
|
2014
Q3 | $105M | Sell |
|
|||||
|
2014
Q2 | $93.7M | Buy |
|
|||||
|
2014
Q1 | $68.4M | Sell |
|
|||||
|
2013
Q4 | $72.2M | Buy |
|
|||||
|
2013
Q3 | $71M | Buy |
|
|||||
|
2013
Q2 | $69.6M | Buy |
|